Cargando…

Apolipoproteins: New players in cancers

Apolipoproteins (APOs), the primary protein moiety of lipoproteins, are known for their crucial role in lipid traffic and metabolism. Despite extensive exploration of APOs in cardiovascular diseases, their roles in cancers did not attract enough attention. Recently, research focusing on the roles of...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Yingcheng, Chen, Jianrui, Ma, Yanbing, Chen, Hongping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732396/ https://www.ncbi.nlm.nih.gov/pubmed/36506554 http://dx.doi.org/10.3389/fphar.2022.1051280

Ejemplares similares

High-density Lipoproteins and Apolipoprotein A-I: Potential New Players in the Prevention and Treatment of Lung Disease
por: Gordon, Elizabeth M., et al.
Publicado: (2016)

Apolipoprotein A-I and Cancer
por: Zamanian-Daryoush, Maryam, et al.
Publicado: (2015)

Apolipoprotein Mimetic Peptides: A New Approach for the Treatment of Asthma
por: Yao, Xianglan, et al.
Publicado: (2012)

Anti-tumorigenic and Platinum-Sensitizing Effects of Apolipoprotein A1 and Apolipoprotein A1 Mimetic Peptides in Ovarian Cancer
por: Marinho, Aline T., et al.
Publicado: (2019)

Inflammation in Renal Diseases: New and Old Players
por: Andrade-Oliveira, Vinicius, et al.
Publicado: (2019)

Importance of Apolipoprotein A-I in Multiple Sclerosis
por: Gardner, Lidia A., et al.
Publicado: (2015)

Protease-Activated Receptor-2 Deficiency Attenuates Atherosclerotic Lesion Progression and Instability in Apolipoprotein E-Deficient Mice
por: Zuo, Pengfei, et al.
Publicado: (2017)

Neurosteroids in Pain Management: A New Perspective on an Old Player
por: Joksimovic, Sonja L., et al.
Publicado: (2018)

MicroRNA-21: An Emerging Player in Bone Diseases
por: Chen, Chen, et al.
Publicado: (2021)

Apolipoprotein A-I Mimetic Peptide L-4F Suppresses Granulocytic-Myeloid-Derived Suppressor Cells in Mouse Pancreatic Cancer
por: Peng, Meiyu, et al.
Publicado: (2020)

Cancer Stem Cell-Exosomes, Unexposed Player in Tumorigenicity
por: Al-Sowayan, Batla S., et al.
Publicado: (2020)

Danlou Tablets Inhibit Atherosclerosis in Apolipoprotein E-Deficient Mice by Inducing Macrophage Autophagy: The Role of the PI3K-Akt-mTOR Pathway
por: Liu, Chunping, et al.
Publicado: (2021)

The Spatiotemporal Regulation of cAMP Signaling in Blood Platelets—Old Friends and New Players
por: Raslan, Zaher, et al.
Publicado: (2015)

A CYPome-wide study reveals new potential players in the pathogenesis of Parkinson’s disease
por: Hartz, Philip, et al.
Publicado: (2023)

Insulin Fused to Apolipoprotein A-I Reduces Body Weight and Steatosis in DB/DB Mice
por: Ardaiz, Nuria, et al.
Publicado: (2021)

Polyphenols as Antitumor Agents Targeting Key Players in Cancer-Driving Signaling Pathways
por: Cháirez-Ramírez, Manuel Humberto, et al.
Publicado: (2021)

(–)-Epigallocatechin-3-Gallate Ameliorates Atherosclerosis and Modulates Hepatic Lipid Metabolic Gene Expression in Apolipoprotein E Knockout Mice: Involvement of TTC39B
por: Wang, Wei, et al.
Publicado: (2018)

Apolipoprotein-A-I for severe COVID-19-induced hyperinflammatory states: A prospective case study
por: Faguer, Stanislas, et al.
Publicado: (2022)

Apolipoprotein A-I attenuates peritoneal fibrosis associated with peritoneal dialysis by inhibiting oxidative stress and inflammation
por: Lu, Jing, et al.
Publicado: (2023)

Corrigendum: (-)-Epigallocatechin-3-Gallate Ameliorates Atherosclerosis and Modulates Hepatic Lipid Metabolic Gene Expression in Apolipoprotein E Knockout Mice: Involvement of TTC39B
por: Wang, Wei, et al.
Publicado: (2018)

Monocyte to high-density lipoprotein and apolipoprotein A1 ratios are associated with bone homeostasis imbalance caused by chronic inflammation in postmenopausal women with type 2 diabetes mellitus
por: Huang, Rong, et al.
Publicado: (2022)

TRPM2 Channel in Microglia as a New Player in Neuroinflammation Associated With a Spectrum of Central Nervous System Pathologies
por: Malko, Philippa, et al.
Publicado: (2019)

Comparison of Mechanisms of Endothelial Cell Protections Between High-Density Lipoprotein and Apolipoprotein A-I Mimetic Peptide
por: Xu, Wenqi, et al.
Publicado: (2019)

Apolipoprotein B/apolipoprotein A1 ratio and mortality among incident peritoneal dialysis patients
por: Zhan, Xiaojiang, et al.
Publicado: (2018)

The Relationship Between Short-Term Surrogate Endpoint Indicators and mPFS and mOS in Clinical Trials of Malignant Tumors: A Case Study of Approved Molecular Targeted Drugs for Non-Small-Cell Lung Cancer in China
por: Rui, Mingjun, et al.
Publicado: (2022)

Effect of Apolipoprotein E ε4 Allele on the Progression of Carotid Atherosclerosis Through Apolipoprotein Levels
por: Ma, Wenbing, et al.
Publicado: (2022)

Apolipoprotein A-II, a Player in Multiple Processes and Diseases
por: Florea, Gabriela, et al.
Publicado: (2022)

Integrated comparative metabolomics and network pharmacology approach to uncover the key active ingredients of Polygonati rhizoma and their therapeutic potential for the treatment of Alzheimer’s disease
por: Wang, Fu, et al.
Publicado: (2022)

Discovery of the key active compounds in Citri Reticulatae Pericarpium (Citrus reticulata “Chachi”) and their therapeutic potential for the treatment of COVID-19 based on comparative metabolomics and network pharmacology
por: Wang, Fu, et al.
Publicado: (2022)

Iron and thiols as two major players in carcinogenesis: friends or foes?
por: Toyokuni, Shinya
Publicado: (2014)

Sortilin in Glucose Homeostasis: From Accessory Protein to Key Player?
por: Blondeau, Nicolas, et al.
Publicado: (2019)

Apolipoprotein A-I mimetic peptides (ApoAI MP) improve oxidative stress and inflammatory responses in Parkinson’s disease mice
por: Jiang, Hongfang, et al.
Publicado: (2022)

Isoquinoline Alkaloids and Indole Alkaloids Attenuate Aortic Atherosclerosis in Apolipoprotein E Deficient Mice: A Systematic Review and Meta-Analysis
por: Zhang, Yibing, et al.
Publicado: (2018)

Atheroregressive Potential of the Treatment with a Chimeric Monoclonal Antibody against Sulfated Glycosaminoglycans on Pre-existing Lesions in Apolipoprotein E-Deficient Mice
por: Brito, Victor, et al.
Publicado: (2017)

Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL
por: Mascolo, Annamaria, et al.
Publicado: (2023)

Commentary: The apolipoprotein A-I mimetic peptide, D-4F, restrains neointimal formation through heme oxygenase-1 up-regulation
por: Li Volti, Giovanni, et al.
Publicado: (2017)

Bazedoxifene Attenuates Abdominal Aortic Aneurysm Formation via Downregulation of Interleukin-6/Glycoprotein 130/Signal Transducer and Activator of Transcription 3 Signaling Pathway in Apolipoprotein E–Knockout Mice
por: Yan, Dan, et al.
Publicado: (2020)

Apolipoprotein M—A Marker or an Active Player in Type II Diabetes?
por: Christoffersen, Christina
Publicado: (2021)

Dose-Effect Relationship of Chitosan and Danshen Combined Injection for Fallopian Tube Recanalization
por: Huang, Chen, et al.
Publicado: (2022)

Nephrotoxicity in a Patient With Inadequate Pain Control: Potential Role of Pharmacogenetic Testing for Cytochrome P450 2D6 and Apolipoprotein L1
por: Tillman, Emma M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sq15qpqph7mr8mbe13qdetj3lv